COVID-19, hypertension and cardiovascular diseases: Should we change the therapy?

Tadic, Marijana; Cuspidi, Cesare; Mancia, Giuseppe; Dell'Oro, Raffaella; Grassi, Guido

Tadic, Marijana; Cuspidi, Cesare; Mancia, Giuseppe; Dell'Oro, Raffaella; Grassi, Guido.

Affiliation

Tadic M; University Hospital "Dr. Dragisa Misovic - Dedinje", Department of Cardiology, Belgrade, Serbia. Electronic address: marijana_tadic@hotmail.com.
Cuspidi C; University of Milan-Bicocca, Milan, Italy; Istituto Auxologico Italiano, Clinical Research Unit, Viale della Resistenza 23, 20036 Meda, Italy.
Mancia G; University of Milan-Bicocca, Milan, Italy; Policlinico di Monza, Monza, Italy.
Dell'Oro R; University of Milan-Bicocca, Milan, Italy.
Grassi G; University of Milan-Bicocca, Milan, Italy.

Pharmacol Res ; 158: 104906, 2020 08.

Article in En | MEDLINE | ID: mdl-32461198

Subject(s)

Cardiovascular Diseases/drug therapy; Cardiovascular Diseases/epidemiology; Coronavirus Infections/drug therapy; Coronavirus Infections/epidemiology; Hypertension/drug therapy; Hypertension/epidemiology; Pneumonia, Viral/drug therapy; Pneumonia, Viral/epidemiology; Renin-Angiotensin System/drug effects; Betacoronavirus; COVID-19; Comorbidity; Coronavirus Infections/diagnosis; Disease Progression; Humans; Pandemics; Pneumonia, Viral/diagnosis; Prognosis; SARS-CoV-2

Key words

COVID-19; Cardiovascular disease; Hypertension; Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia, Viral / Renin-Angiotensin System / Cardiovascular Diseases / Coronavirus Infections / Hypertension Type of study: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Pharmacol Res Journal subject: FARMACOLOGIA Year: 2020 Type: Article

Fulltext

XML

PubMed Links

Search on Google